Atom Investors’s Axcelis ACLS Stock Holding History

Atom Investors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,910	Closed	-$553K	–	491
2024 Q4	$553K	Buy	+7,910	New	+$657K	0.07%	303
2023 Q3	–	Sell	-2,103	Closed	-$386K	–	422
2023 Q2	$386K	Buy	+2,103	New	+$303K	0.15%	144

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Atom Investors's ACLS Position: Q1 2025 in Review

Atom Investors sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 7,910 shares — an estimated $553K sold.

Atom Investors first reported a position in ACLS in Q2 2023 and held it in 2 quarters. The position peaked at $553K in Q4 2024. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

Atom Investors reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
Atom Investors sold 7,910 Axcelis shares in Q1 2025, an estimated $553K.
Atom Investors first reported a position in Axcelis in Q2 2023 and held it in 2 quarters.
Atom Investors's Axcelis position peaked at $553K in Q4 2024.
306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Atom Investors's 13F filing for Q1 2025, filed 15 May 2025.